Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Japanese Lead Extraction Registry (J-LEX): Annual Report in 2024.

Journal of arrhythmia·2025
Same author

Cancer Incidence Rates Between BRCA1/2 Pathogenic Variant Carriers and Non-Carriers in Real-World Clinical Practice.

The Tohoku journal of experimental medicine·2025
Same author

Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report.

Cancer science·2025
Same author

A randomized controlled trial of two pulsed field ablation systems for paroxysmal atrial fibrillation: the DUAL-PULSE trial rationale and design.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

Risk Prediction Models of Cardiotoxicity in Patients With Breast Cancer: Multicenter Prospective CHECK HEART-BC Study.

JACC. Asia·2025
Same author

The Japanese Catheter Ablation Registry (J-AB): Annual Report in 2023.

Journal of arrhythmia·2025

相关实验视频

Updated: May 13, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

血清脱氧核糖核酶I活性作为急性心肌梗塞急性心肌梗塞早期新型标记物的诊断用途.

Yasuyuki Kawai1, Masahiro Yoshida, Kenichiro Arakawa

  • 1Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Circulation
|May 19, 2004
PubMed
概括

急性心肌梗塞 (AMI) 的早期诊断至关重要. 新的研究表明,3小时内血清脱氧核糖核酶I (DNase I) 活性升高可以帮助检测AMI.

更多相关视频

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
06:18

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

Published on: September 17, 2021

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

相关实验视频

Last Updated: May 13, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm
06:18

Measurement of Myocardial Lactate Production for Diagnosis of Coronary Microvascular Spasm

Published on: September 17, 2021

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

科学领域:

  • 生物化学 生物化学
  • 心脏病学 心脏病学
  • 临床诊断 临床诊断 临床诊断

背景情况:

  • 早期诊断急性心肌梗塞 (AMI) 是具有挑战性的,因为心脏标志物释放的延迟和不明确的心电图发现.
  • 需要一个可靠的血清生物标志物来快速检测AMI.

研究的目的:

  • 评估血清脱氧核糖核酶I (DNase I) 作为潜在的AMI早期诊断标记物.
  • 将AMI患者的DNase I水平与其他心脏病患者的水平进行比较.

主要方法:

  • 来自被诊断患有AMI,不稳定性胸痛,稳定性胸痛和其他疾病的患者的血清样本被分析.
  • 在所有患者群体中量化了血清脱氧核糖酶I (DNase I) 活性水平.

主要成果:

  • 在AMI患者表现出显著升高的血清DNase I活性 (21.7+/-5.10U/L) 在症状发作后大约3小时内.
  • 在AMI患者中,DNase I水平明显高于不稳定性胸痛 (10.4+/-4.41U/L),稳定性胸痛 (10.8+/-3.70U/L) 和其他疾病 (9.22+/-4.16U/L) 的水平.
  • 血清DNase I活性显示时间依赖性下降,在24小时内恢复到基线.

结论:

  • 血清DNase I活性显示出作为急性心肌梗塞早期检测的新生物标志物的潜力.
  • 这一发现可以提高AMI诊断在临床环境中的及时性和准确性.